Diabetic gastroparesis involves progressive damage to the nerves that control stomach function, causing food to move more slowly through your digestive system.

A total of 205 adult women (mean age, 52.7 years) with diabetic gastroparesis and delayed gastric emptying were randomly allocated (1:1) to placebo or MNS administered in either nostril, four ...

Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10 ...

The new report by Expert Market Research titled, ‘Global Diabetic Gastroparesis Treatment Market Report and Forecast 2021-2026’, gives in-depth ...

Here’s what you should know: 1. Acute and recurrent diabetic gastroparesis primarily affects women. Approximately 80 percent of gastroparesis sufferers are women. 2. Existing oral treatments are ...

It is estimated that one-third of cases of gastroparesis are linked to diabetes, a disease that can cause nerve damage. It adds to the health risks of people living with diabetes because the ...

Diabetes is a major cause for gastroparesis, but it also can follow surgery and some medications can trigger the problem. This new treatment strategy should help, regardless of the cause, Sharma says.

Additional diet information for people with gastroparesis and kidney disease can be found here, accessed April 3, 2009. From the May 01, 2009 Issue of Renal and Urology News ...

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI® Oct. 28, 2024 7:00 AM ET Evoke Pharma, Inc. (EVOK) ...

Evoke Pharma Inc (NASDAQ:EVOK) shares are trading higher Monday after the company presented GLP-1 data for users with diabetic gastoparesis using GIMOTI showing statistically significant improvements.

Diabetic gastroparesis most commonly occurs in patients with poorly controlled or long-standing (meaning 5 years or longer) diabetes, according to the Food and Drug Administration.